Brief: Novabay Pharmaceuticals Announces Agreement With Biostem Technologies To Commercialize Amniotic Tissue Allograft
11/09/2023 13:34
Sept 11 (Reuters) - Biostem Technologies Inc BSEM.PK :
* NOVABAY PHARMACEUTICALS ANNOUNCES AGREEMENT WITH BIOSTEM
TECHNOLOGIES TO COMMERCIALIZE AMNIOTIC TISSUE ALLOGRAFT AS
AVENOVA ALLOGRAFT
Source text for Eikon: ID:nBw5PkYYTa
Further company coverage: BSEM.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioStem Technologies
See all newsBrief: Biostem Technologies Files Prospectus For Resale Of Up To 2.2 Mln Shares By Selling Stockholders - Filing
BioStem Technologies, Inc. reports results for the quarter ended June 30 - Earnings Summary
NASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Biostem Technologies Announces Appointment Of Three New Members To Its Board Of Directors